A case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib
Crossref DOI link: https://doi.org/10.1186/s12885-016-2657-7
Published Online: 2016-08-12
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Maleka, A.
Åström, G.
Byström, P.
Ullenhag, G. J.
